Votrient 200 mg (Pazopanib)

Active Ingredient:Pazopanib
Dosage Form:Tablet
Available Strength:200mg
Manufacturer:GlaxoSmithKline Pharmaceuticals Ltd
Packaging:30 tablets in 1 strip
Therapeutic Use:Kidney cancer, Soft tissue sarcoma
Pack Insert/Leaflet:Yes
Production Capacity:1 Million Tablet's/Month

Description

Reviews

There are no reviews yet.

Be the first to review “Votrient 200 mg (Pazopanib)”

Your email address will not be published. Required fields are marked *